Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA

Watchlist Manager
Sun Pharmaceutical Industries Ltd Logo
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Watchlist
Price: 1 731.45 INR -1.56% Market Closed
Market Cap: 4.2T INR

Intrinsic Value

The intrinsic value of one SUNPHARMA stock under the Base Case scenario is 1 079.36 INR. Compared to the current market price of 1 731.45 INR, Sun Pharmaceutical Industries Ltd is Overvalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SUNPHARMA Intrinsic Value
1 079.36 INR
Overvaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Sun Pharmaceutical Industries Ltd

SUNPHARMA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for SUNPHARMA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
IN
Pharmaceuticals
Market Cap
4.2T INR
IPO
Jan 1, 1994
IN
Pharmaceuticals
Market Cap
4.2T INR
IPO
Jan 1, 1994
Price
â‚ąfalse
EPS
â‚ąfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Sun Pharma’s reliance on the U.S. specialty and generics market leaves it vulnerable to aggressive pricing pressure, which could compress margins and slow top-line growth if insurers and pharmacy benefit managers continue to push for lower prices.

Bull Theses

A well-rounded specialty portfolio—particularly in high-growth areas such as dermatology, ophthalmology, and oncology—positions Sun Pharma to command premium pricing and drive robust profit expansion in global markets.

Show More Less
How do you feel about SUNPHARMA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Sun Pharmaceutical Industries Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sun Pharmaceutical Industries Ltd

Current Assets 460.7B
Cash & Short-Term Investments 207.6B
Receivables 129.9B
Other Current Assets 123.2B
Non-Current Assets 420.5B
Long-Term Investments 68.1B
PP&E 112.5B
Intangibles 182.2B
Other Non-Current Assets 57.7B
Efficiency

Free Cash Flow Analysis
Sun Pharmaceutical Industries Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sun Pharmaceutical Industries Ltd

Revenue
516B INR
Cost of Revenue
-104.9B INR
Gross Profit
411.1B INR
Operating Expenses
-288.6B INR
Operating Income
122.5B INR
Other Expenses
-8.1B INR
Net Income
114.3B INR
Fundamental Scores

SUNPHARMA Profitability Score
Profitability Due Diligence

Sun Pharmaceutical Industries Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Years Revenue Growth
63/100
Profitability
Score

Sun Pharmaceutical Industries Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

SUNPHARMA Solvency Score
Solvency Due Diligence

Sun Pharmaceutical Industries Ltd's solvency score is 96/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
96/100
Solvency
Score

Sun Pharmaceutical Industries Ltd's solvency score is 96/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SUNPHARMA Price Targets Summary
Sun Pharmaceutical Industries Ltd

Wall Street analysts forecast SUNPHARMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SUNPHARMA is 2 062.75 INR with a low forecast of 1 489.75 INR and a high forecast of 2 572.5 INR.

Lowest
Price Target
1 489.75 INR
14% Downside
Average
Price Target
2 062.75 INR
19% Upside
Highest
Price Target
2 572.5 INR
49% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SUNPHARMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SUNPHARMA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SUNPHARMA stock?

The intrinsic value of one SUNPHARMA stock under the Base Case scenario is 1 079.36 INR.

Is SUNPHARMA stock undervalued or overvalued?

Compared to the current market price of 1 731.45 INR, Sun Pharmaceutical Industries Ltd is Overvalued by 38%.

Back to Top